Official Announcement 📢
Nova Technologies releases the following update regarding regulatory observation for the Nova Medical Nanites clinical trial.
Observer Participation
Nova Technologies confirms that regulatory institutions from across the globe have formally confirmed observer participation in the clinical trial.
The following institutions have confirmed:
• World Health Organization
• Food and Drug Administration
• Centers for Disease Control and Prevention
• European Medicines Agency
• National Medical Products Administration
• Medicines and Healthcare products Regulatory Agency
National Government Observers
Observer delegations have been confirmed from 79 nations across all inhabited continents.
The full list of participating nations will be published separately upon final confirmation of all delegations.
What Observers Will Have Access To
Participating observers will have:
